Loading...
Loading...
Among the 7 tracked institutional investors we monitor, KALV (KALVISTA PHARMACEUTICALS INC) is held with a combined value of $245.00M across 12,667,121 shares. The largest holder is BlackRock, Inc. with a position worth $76.41M (0.00% of their portfolio). VANGUARD GROUP INC opened a new position in the most recent quarter. 4 funds increased their holdings. 2 funds reduced their position.
Total Institutional Value
$245.00M
Total Shares Held
12,667,121
Institutional Holders
7
| # | Fund | Value↓ | Portfolio % | Change |
|---|---|---|---|---|
| 1 | BlackRock, Inc. | $76.41M | 0.00% | +1.1% |
| 2 | Point72 Asset Management, L.P. | $43.02M | 0.06% | -6.4% |
| 3 | VANGUARD GROUP INC | $40.52M | 0.00% | New |
| 4 | STATE STREET CORP | $39.37M | 0.00% | +2.3% |
| 5 | MILLENNIUM MANAGEMENT LLC | $38.49M | 0.02% | -34.5% |
| 6 | FMR LLC | $3.78M | 0.00% | +68.0% |
| 7 | CITADEL ADVISORS LLC | $3.41M | 0.00% | +157.6% |
As of the latest SEC 13F filings, BlackRock, Inc. is the largest institutional holder of KALV with a position worth $76.41M, representing 0.00% of their portfolio. In total, 7 institutional investors hold KALV with a combined value of $245.00M.
In the most recent quarter, 1 fund opened a new position in KALV. Additionally, 4 increased their holdings and 2 reduced their positions.
Institutional investors hold $245.00M worth of KALV stock across 7 positions. The largest institutional holder is BlackRock, Inc. with $76.41M in holdings.
A 13F filing is a quarterly report required by the SEC from institutional investment managers with over $100 million in assets. It discloses their holdings in U.S. equities. For KALV, these filings reveal which major funds are accumulating or reducing positions, providing insights into institutional sentiment.
Get notified when hedge funds change their KALV positions.